ROUSE ESTATES LIMITED
Company number 00379399 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
1. Financial Health Score: B-
Explanation: Rouse Estates Limited is akin to a patient with a strong skeleton but sluggish circulation. The company benefits from a robust, debt-free asset base—primarily a portfolio of five investment properties—that provides excellent long-term security. However, the business is currently exhibiting symptoms of acute short-term illiquidity, with current liabilities significantly exceeding current assets, and a recent dip in retained earnings indicating a sluggish metabolic rate (profitability). The lack of long-term debt keeps the patient out of the emergency room, but the low cash reserves require immediate lifestyle adjustments to ensure ongoing financial wellness.
2. Key Vital Signs
- Net Assets (Skeletal Health): £392,221
- Interpretation: The company’s "bone density" is excellent. Net assets remain strongly positive, providing a sturdy structural foundation. However, this is a slight contraction from the prior year's £402,001, indicating a minor loss of bone mass.
- Current Ratio (Blood Pressure): 0.49:1
- Interpretation: Calculated as Current Assets (£2,247) divided by Current Liabilities (£4,526). A healthy current ratio is typically between 1.5 and 2.0. A ratio below 1 means the company has "low blood pressure"—it does not have enough liquid assets to cover its short-term debts without converting long-term assets (the properties) into cash.
- Cash at Bank (Circulation): £1,511
- Interpretation: Cash levels have dropped significantly from £5,759 in 2024. The patient's circulation is restricted. For a property-owning entity, having less than £2,000 in the bank leaves virtually no margin for unexpected repairs, void periods, or sudden expenditures.
- Profitability (Metabolism): Loss of £9,780
- Interpretation: The Profit and Loss reserve dropped from £395,401 to £385,621, indicating a loss for the year. The company's metabolism is currently burning more cash than it is generating, which requires investigation into whether this is due to non-cash adjustments (like provisions) or operational underperformance.
- Leverage (Cholesterol): 0%
- Interpretation: There is no long-term debt on the balance sheet. The "cholesterol" levels are pristine. The company owns its assets outright, which provides immense financial flexibility and shields it from interest rate shocks.
3. Diagnosis
Asset-Rich, Cash-Poor with Latent Tax Exposure
The financial data reveals a business that is fundamentally secure in the long term but experiencing short-term financial tightness.
The primary "symptom of distress" is the net current liability position of (£2,279). The company owes more in the short term (mostly to trade creditors, taxation, and other creditors) than it holds in cash and debtors. In medical terms, the patient is slightly fluid-overloaded with immediate obligations but dehydrated in terms of ready cash. If a tenant defaults on rent or a property requires emergency maintenance, the company would struggle to cover the costs from its current accounts without securing external funding or relying on director support.
A closer look at the anatomy reveals a £5,800 "provision for liabilities" that appeared this year, which didn't exist in 2024. This is likely a latent condition—potentially deferred tax arising from the revaluation of the investment properties. The properties are valued at £400,000 on a fair value basis, compared to a historical cost of just £42,809. While this revaluation makes the balance sheet look incredibly strong, it can create a deferred tax liability that slowly bleeds into the P&L reserve over time.
Finally, the recent loss of £9,780 suggests that operating costs, taxation, and provisions have outpaced rental income for the year. With only one employee (likely a director managing the portfolio), overheads should be minimal, making this loss a symptom that requires a closer look at the income statement details to ensure rental yields are healthy.
4. Recommendations
To improve the financial wellness and build resilience, the following "prescriptions" are recommended:
- Improve Cash Flow Circulation (Liquidity Management): The company must prioritize building a cash buffer. Consider retaining a portion of rental income in the business rather than distributing it to shareholders. A target of at least 3 to 6 months of operating expenses should be held in cash to act as an immune system boost against unexpected property voids or repairs.
- Monitor the Short-Term Obligations (Lowering Blood Pressure): The directors should ensure that the £4,526 in current liabilities can be serviced smoothly from upcoming rental receipts. If cash remains tight, short-term director loans could act as a temporary transfusion to clear trade and tax creditors, clearing the current liability blockage.
- Investigate the Metabolic Slowdown (Profitability Review): Conduct a thorough review to diagnose the exact cause of the £9,780 loss. If it is driven by non-cash expenses like the £5,800 provision, the operational cash flow may actually be healthy. If rental income is falling short of operating costs, rental yields need to be reviewed and potentially increased to match market rates.
- Review the Property Valuation Policy: The £400,000 valuation (vs £42k cost) is a significant multiplier. While it accurately reflects the asset's worth, the directors should be aware that this creates a deferred tax time-bomb if the properties are ever sold. Ensure that a long-term exit strategy is in place to handle potential Capital Gains Tax liabilities.